Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 12 recruiting now later-stage tilt

Analgesia: later-stage trial registry

12 of 20 indexed Analgesia trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #848 of 28,707 conditions by registered trial count.

20 US clinical trials · 12 currently recruiting · #848 of 28,707 conditions by registered trial count

Analgesia: 20 US clinical trials tracked, 12 recruiting.

Analgesia is the subject of 20 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 10 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of Pittsburgh, running 2 of these trials.

Enrollment posture brief

Registry condition analgesia

OPEN 12 | RECR 60% | LATE 10 | EARLY 3 | RANK #848 | SPON 2

Nearest open-share peer: Abuse, Drug (60% recruiting · 5 trials)

Analgesia (this)60%Advanced or Metastatic Solid55%ALS50%Abdominal Pain25%Acute Myocardial Infarction25%
Open-enrollment share among volume-matched conditions near Analgesia

Analgesia lists 12 open slots (60% of 20 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Analgesia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Analgesia is recruiting above its size-band peers.

    12 of 20 indexed trials (60%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Analgesia trials is spread across many organizations.

    University of Pittsburgh accounts for 2 of 20 trials (10%). 19 distinct sponsors appear on at least one study for this condition label.

  3. Typical Analgesia enrolment sits around 100 participants.

    Median target enrolment is 100 among the 20 trials that report a genuine target (sentinel values excluded). 10 of those (50%) plan for fewer than 100 participants.

  4. Analgesia research is mostly interventional.

    19 interventional and 1 observational studies make up this index (95% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 21Phase 32Phase 48

Open and recent trials

20 total, page 1 of 1

RECRUITING NA 180 participants

Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery

Inova Health Care Services

NCT07185425

RECRUITING NA 180 participants

Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control

Hawaii Pacific Health

NCT04399707

RECRUITING Early Phase 1 136 participants

RM1 Project 1 - tAN Naloxone

Medical University of South Carolina

NCT05490134

RECRUITING Phase 4 120 participants

Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia

Vanderbilt University Medical Center

NCT05988710

RECRUITING Phase 4 100 participants

Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO

NYU Langone Health

NCT06952556

RECRUITING Phase 2 100 participants

Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population

Texas Scottish Rite Hospital for Children

NCT06559215

RECRUITING Phase 4 86 participants

Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

Hackensack Meridian Health

NCT05776953

RECRUITING Phase 4 80 participants

Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery

University of Wisconsin, Madison

NCT06213454

RECRUITING NA 60 participants

Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain

The University of Texas Medical Branch, Galveston

NCT05555485

RECRUITING Phase 1 60 participants

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

Icahn School of Medicine at Mount Sinai

NCT06653400

RECRUITING NA 40 participants

TENS Unit for Analgesia During IUD Insertion

Tufts Medical Center

NCT06240260

RECRUITING NA 40 participants

Offset Mechanisms in Evaluation of Lumbar Medial Branch Blocks

University of Pittsburgh

NCT05961800

COMPLETED 110 participants

Brain Biomarker of Endogenous Analgesia in Patients With Chronic Knee Pain

University of Pittsburgh

NCT05003323

COMPLETED Phase 3 106 participants

Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

NCT04117074

COMPLETED NA 100 participants

High Level Pulsed Heat Versus Low Level Steady Heat in Subjects With Chronic Low Back Pain

Soovu Labs

NCT04109703

COMPLETED Phase 4 100 participants

Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques

Brigham and Women's Hospital

NCT04814537

COMPLETED Phase 3 80 participants

Liposomal Bupivacaine Versus Non-liposomal Bupivacaine for Total Shoulder Arthroplasty

University of Virginia

NCT04974385

COMPLETED Phase 4 31 participants

Pecto-intercostal Fascial Block (PIFB) for Postop Analgesia Following Sternotomy in Cardiac Surgery Patients

Wake Forest University Health Sciences

NCT05676814

COMPLETED Phase 4 30 participants

Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram

University of Pennsylvania

NCT01925469

COMPLETED Phase 4 24 participants

TAP-patients With Robotic Assisted Lap Prostatectomy

Pacira Pharmaceuticals

NCT01582477

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1
Phase 3 2
Phase 4 8

Named interventions

Most-linked intervention names on Analgesia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Liposomal bupivacaine Drug
2 trials
Saline spray Drug
1 trials
Benzocaine Drug
1 trials
Thoracic epidural analgesia (bupivacaine) Other
1 trials
PIFB with adjuvants Drug
1 trials
Pecto-intercostal Fascial Block (PIFB) Drug
1 trials
Low Level (37 degrees C) delivered by the control device Generation 5 devices from Soovu Labs Inc. Device
1 trials
High Level Pulsed Heat delivered by Generation 5 devices from Soovu Labs Inc. Device
1 trials

US sites by state

Facility locations filed on Analgesia trials. A trial with sites in several states counts in each.

Pennsylvania 3 trials
Massachusetts 3 trials
Virginia 2 trials
Texas 2 trials
New York 2 trials
Wisconsin 1 trials
Tennessee 1 trials
South Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Analgesia page

20 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Analgesia condition card totals 20 registered trials; most-linked intervention Liposomal bupivacaine; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.